Scholarlink

Purpose <p>Prostate biopsy is needed for diagnosing prostate cancer, the commonest cancer affecting men. Due to its lower rates of post-procedural infection compared to transrectal approaches, the use of transperineal approaches may increase. There is limited current evidence of serum biomarker changes following transperineal template prostate biopsy (TTPB) and their correlation with clinical outcomes.</p> Methods <p>A within-group, repeated-measures observational study was employed. Venous blood samples were taken pre-TTPB (baseline) and at 30 and 240 min post-TTPB in 6 patients (median age 67 years, age range 63–76). The serum concentrations of 13 selective human growth factors were measured using the Luminex® Performance Assay. Patient medical notes were reviewed to assess clinical outcomes.</p> Results <p>Following TTPB, significant increases were demonstrated in the serum concentration of PDGF-AA and TGF-alpha (<i>p</i> ≤ 0.05). Significant decreases were observed in the serum concentration of EGF and Flt3 ligand (<i>p</i> ≤ 0.05). There were no significant differences in the serum concentrations following TTPB in: CD40 Ligand, G-CSF, GRO-beta, IL-8, IL-33, MIP-3 beta, PDGF-AB/BB, TRAIL, and VEGF (<i>p</i> ≥ 0.05). There were no significant post-operative complications.</p> Conclusions <p>The significant increases in serum PDGF-AA and TGF-α, and significant decreases in serum EGF and Flt3 ligand could be explained by post-procedural inflammatory or paraneoplastic mechanisms. Further research into these biomarkers with larger cohorts may enable further understanding of their role pre- and post-operatively in TTPB and their correlation with clinical outcomes. This may be used to develop a clinical tool to predict or identify patients at risk of early post-TTPB complications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The effect of transperineal template prostate biopsy (TTPB) on selective serum biomarkers: a clinical-pilot observational study

  • 期刊论文

  • 发表日期：

    2026年1月30日

查看全文
  • Marcus Dyer,
  • Peter Ella-Tongwiis,
  • Nana Yaa Frempomaa Snyper,
  • Iqbal Shergill,
  • Stephen Fôn Hughes

摘要

Purpose

Prostate biopsy is needed for diagnosing prostate cancer, the commonest cancer affecting men. Due to its lower rates of post-procedural infection compared to transrectal approaches, the use of transperineal approaches may increase. There is limited current evidence of serum biomarker changes following transperineal template prostate biopsy (TTPB) and their correlation with clinical outcomes.

Methods

A within-group, repeated-measures observational study was employed. Venous blood samples were taken pre-TTPB (baseline) and at 30 and 240 min post-TTPB in 6 patients (median age 67 years, age range 63–76). The serum concentrations of 13 selective human growth factors were measured using the Luminex® Performance Assay. Patient medical notes were reviewed to assess clinical outcomes.

Results

Following TTPB, significant increases were demonstrated in the serum concentration of PDGF-AA and TGF-alpha (p ≤ 0.05). Significant decreases were observed in the serum concentration of EGF and Flt3 ligand (p ≤ 0.05). There were no significant differences in the serum concentrations following TTPB in: CD40 Ligand, G-CSF, GRO-beta, IL-8, IL-33, MIP-3 beta, PDGF-AB/BB, TRAIL, and VEGF (p ≥ 0.05). There were no significant post-operative complications.

Conclusions

The significant increases in serum PDGF-AA and TGF-α, and significant decreases in serum EGF and Flt3 ligand could be explained by post-procedural inflammatory or paraneoplastic mechanisms. Further research into these biomarkers with larger cohorts may enable further understanding of their role pre- and post-operatively in TTPB and their correlation with clinical outcomes. This may be used to develop a clinical tool to predict or identify patients at risk of early post-TTPB complications.